Stock listing
Lepu Biopharma Co. Ltd. Class H
Selected listing: 2157 · HKEX · HKD · HK
Lepu Biopharma Co. Ltd. Class H (HKEX:2157), Health Technology. Latest release Nov 21, 2025: BioDlink and Lepu Biopharma Celebrate Successful Launch…
- Ticker
- HKEX:2157
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Lepu Biopharma Co. Ltd. Class H
The company focuses on biopharmaceuticals, contributing to advancements in healthcare. Investors can find detailed information about Lepu Biopharma's operations and performance on its public company page.
Latest news from Lepu Biopharma Co. Ltd. Class H
BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
November 21, 2025
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
November 5, 2025
Research Lepu Biopharma Co. Ltd. Class H
Lepu Biopharma Co. Ltd. Class H company profile
View the public company page for Lepu Biopharma Co. Ltd. Class H on 6ix.
Lepu Biopharma Co. Ltd. Class H news
Read company news and market updates connected to Lepu Biopharma Co. Ltd. Class H.
Lepu Biopharma Co. Ltd. Class H investor events
Find investor webinars, events, and replay context for Lepu Biopharma Co. Ltd. Class H.